Promius Pharma Employees Band Together to Fundraise for Hurricane Victims

PRINCETON, N.J., Nov. 13, 2017 /PRNewswire/ -- Promius Pharma LLC today announced that its employees raised $12,715 to support American Red Cross relief efforts to assist those affected by the recent hurricanes. Additionally, Promius' parent company Dr. Reddy's Laboratories matched this donation for a combined contribution of $25,215.

Promius sales and marketing teams took a creative approach to fundraising by competing against one another in a "fidget spinner challenge." Participants submitted videos of themselves using the gadget, often in attention-grabbing or humorous ways. For each video submitted, Promius donated money to the relief effort. In total, more than 100 videos were submitted.

"The core mission of our company, 'The Power of Humans Being,' compels us to work together to make a positive impact in our communities," shared Garth Thomas, Head Dermatology Sales & Marketing at Promius Pharma. "We couldn't be prouder of the generosity and commitment to supporting those affected by the recent storms."

About Promius Pharma LLC
Promius Pharma is a wholly owned subsidiary of Dr. Reddy's Laboratories, one of the largest and most respected pharmaceutical companies in the world. With a robust commercial infrastructure and extensive research and development capabilities through its parent company, Promius Pharma is committed to bringing new products to market that meet patients' needs in dermatology and neurology. For more information, visit www.promiuspharma.com.

Contact information:
Promius Pharma, LLC
107 College Rd E
Princeton, NJ 08540
www.promiuspharma.com

Media Relations:
Lori McCreary (USA)
[email protected]
+1 (609) 375-2995

Copyright 2017 Promius Pharma, LLC

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganisation , including related integration issues. The company assumes no obligation to update any information contained herein.

SOURCE Promius Pharma LLC

Related Links

http://www.greaterthanone.com